Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
0.420
-0.005 (-1.20%)
At close: Feb 21, 2025, 4:00 PM
0.402
-0.018 (-4.36%)
After-hours: Feb 21, 2025, 4:56 PM EST
Spruce Biosciences Stock Forecast
SPRB's stock price has decreased by -91.98% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Spruce Biosciences stock have an average target of 2.17, with a low estimate of 1.50 and a high estimate of 3.00. The average target predicts an increase of 416.67% from the current stock price of 0.42.
Analyst Consensus: Hold
* Price targets were last updated on Dec 11, 2024.
Analyst Ratings
The average analyst rating for Spruce Biosciences stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 16, 2024 |
| Guggenheim | Guggenheim | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 12, 2024 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades $3 | Buy → Hold | Downgrades | $3 | +614.29% | Dec 11, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $2 → $1.5 | Hold | Reiterates | $2 → $1.5 | +257.14% | Dec 11, 2024 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
Financial Forecast
Revenue This Year
5.20M
from 10.09M
Decreased by -48.51%
Revenue Next Year
2.04M
from 5.20M
Decreased by -60.73%
EPS This Year
-0.95
from -1.24
EPS Next Year
-0.58
from -0.95
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 7.4M | 6.3M | 12.1M | |||
| Avg | 5.2M | 2.0M | 5.6M | |||
| Low | 4.1M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -26.2% | 21.3% | 491.9% | |||
| Avg | -48.5% | -60.7% | 175.0% | |||
| Low | -59.2% | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.91 | -0.28 | -0.18 | |||
| Avg | -0.95 | -0.58 | -0.66 | |||
| Low | -0.97 | -0.90 | -1.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.